These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 14712485
1. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Hartmann C, Nümann A, Mueller W, Holtkamp N, Simon M, von Deimling A. Int J Cancer; 2004 Mar 01; 108(6):839-44. PubMed ID: 14712485 [Abstract] [Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
3. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas. Nakamura M, Ishida E, Shimada K, Kishi M, Nakase H, Sakaki T, Konishi N. Lab Invest; 2005 Feb 01; 85(2):165-75. PubMed ID: 15592495 [Abstract] [Full Text] [Related]
4. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Daido S, Takao S, Tamiya T, Ono Y, Terada K, Ito S, Ouchida M, Date I, Ohmoto T, Shimizu K. Oncol Rep; 2004 Oct 01; 12(4):789-95. PubMed ID: 15375501 [Abstract] [Full Text] [Related]
5. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP. Neurosurgery; 1995 Oct 01; 37(4):764-73. PubMed ID: 8559307 [Abstract] [Full Text] [Related]
6. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade. Ino Y, Silver JS, Blazejewski L, Nishikawa R, Matsutani M, von Deimling A, Louis DN. J Neuropathol Exp Neurol; 1999 Aug 01; 58(8):881-5. PubMed ID: 10446812 [Abstract] [Full Text] [Related]
7. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Jeng YM, Hsu HC. Int J Cancer; 2003 Jul 10; 105(5):625-9. PubMed ID: 12740910 [Abstract] [Full Text] [Related]
8. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis. Seng TJ, Ichimura K, Liu L, Tingby O, Pearson DM, Collins VP. Genes Chromosomes Cancer; 2005 Jun 10; 43(2):181-93. PubMed ID: 15770670 [Abstract] [Full Text] [Related]
9. The retinoblastoma gene is involved in malignant progression of astrocytomas. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN. Ann Neurol; 1994 Nov 10; 36(5):714-21. PubMed ID: 7979217 [Abstract] [Full Text] [Related]
10. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q. von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG. Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236 [Abstract] [Full Text] [Related]
11. Molecular pathogenesis of pediatric astrocytic tumors. Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N. Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574 [Abstract] [Full Text] [Related]
12. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W. Oncol Rep; 2004 Jan 15; 11(1):207-11. PubMed ID: 14654927 [Abstract] [Full Text] [Related]
13. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas. Kaulich K, Blaschke B, Nümann A, von Deimling A, Wiestler OD, Weber RG, Reifenberger G. J Neuropathol Exp Neurol; 2002 Dec 15; 61(12):1092-9. PubMed ID: 12484572 [Abstract] [Full Text] [Related]
14. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region. Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H. Oncogene; 1998 Feb 26; 16(8):1009-19. PubMed ID: 9519875 [Abstract] [Full Text] [Related]
15. Loss of heterozygosity on chromosome 22 in human ependymomas. Huang B, Starostik P, Kühl J, Tonn JC, Roggendorf W. Acta Neuropathol; 2002 Apr 26; 103(4):415-20. PubMed ID: 11904762 [Abstract] [Full Text] [Related]
16. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression. Oskam NT, Bijleveld EH, Hulsebos TJ. Int J Cancer; 2000 Feb 01; 85(3):336-9. PubMed ID: 10652423 [Abstract] [Full Text] [Related]
17. Absence of mutation of the p73 gene in astrocytic neoplasms. Alonso ME, Bello MJ, Lomas J, Gonzalez-Gomez P, Arjona D, De Campos JM, Gutierrez M, Isla A, Vaquero J, Rey JA. Int J Oncol; 2001 Sep 01; 19(3):609-12. PubMed ID: 11494043 [Abstract] [Full Text] [Related]
18. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM. Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255 [Abstract] [Full Text] [Related]
19. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors. Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Hayakawa T. Neurol Med Chir (Tokyo); 1997 Aug 01; 37(8):606-10; discussion 611. PubMed ID: 9301196 [Abstract] [Full Text] [Related]
20. Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Huang B, Starostik P, Schraut H, Krauss J, Sörensen N, Roggendorf W. Acta Neuropathol; 2003 Oct 01; 106(4):357-62. PubMed ID: 12898154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]